Stratatech Corporation Email Format

BiotechnologyUnited States51-200 Employees

Stratatech Corporation is a United States-based biotechnology research company focused on regenerative medicine and cell-based therapeutics for skin injuries. Historically, the firm has pursued therapies aimed at treating severe burns and other complex skin defects, with the goal of reducing the need for painful skin harvest and transplantation. The company is mid-sized and operates within the broader biotechnology sector; in 2016 it was acquired by Mallinckrodt, placing it within a larger corporate framework.

In November 2023, Stratatech announced collaborations with the Armed Forces Institute of Pathology, the University of Wisconsin-Madison, the University of Wisconsin-Milwaukee, and the Waisman Clinical Biomanufacturing Facility to advance a project. These partnerships indicate engagement with academic and clinical manufacturing partners to support translational research and potential clinical-scale development in regenerative medicine.

Get verified Stratatech Corporation emails free

Company overview Employee directory